Human Microbiome Therapeutics Market Size (USD 1817.1 M) by 2032 By Type (Fructo-Oligosaccharides, Galacto-Oligosaccharides, Inulin), by applications covered (Antibiotic-Associated Diarrhoea (AAD), Infectious Childhood Diarrhoea, Cholesterol, Inflammatory Bowel Disease (IBD), Blood Pressure, Lactose Intolerance, Weight Loss, Vitamin Production, Bacterial Vaginosis (BV), Others) and Regional Forecast to 2032